Published in Women's Health Weekly, November 29th, 1999
S. Couillard, of the University of Quebec, and associates compared EM-652.HCL used alone or in conjunction with radiation therapy and Caelyx. Their study, entitled, "Effects of the Antiestrogen Em-652.hcl in Combination with Radiotherapy and/or Caelyx on ZR-75-1 Human Breast Tumor Growth in Nude Mice," was presented at the 6th International Congress on Hormones and Cancer, held September 5-9, 1999, in Jerusalem, Israel.
"The present data indicate that combined treatment using EM-652.HCI with chemotherapeutic agents and/or radiotherapy can produce a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.